Applying Dutch and US versions of the BSID-II in Dutch children born preterm leads to different outcomes

J J Westera1, B A Houtzager, B Overdiek

  • 1Emma Children's Hospital AMC, Department of Neonatology, Amsterdam, The Netherlands.

Insights

Using Dutch versus US norms for the Bayley Scales of Infant Development-2nd edition (BSID-II) significantly impacted developmental scores in preterm infants. Clinically relevant differences were observed, particularly in the early months, suggesting potential bias in normative data.

Area of Science:

  • Developmental Psychology
  • Pediatric Neurodevelopment
  • Psychometrics

Background:

  • Accurate assessment of infant development is crucial for early intervention.
  • The Bayley Scales of Infant Development-2nd edition (BSID-II) is a widely used tool for evaluating developmental outcomes.
  • Cross-cultural application of standardized tests requires careful consideration of normative data.

Purpose of the Study:

  • To compare developmental outcomes in preterm infants using Dutch versus US test procedures and norms of the BSID-II.
  • To identify potential discrepancies in developmental scores attributed to differing normative data.
  • To evaluate the clinical relevance of observed Dutch-US differences in BSID-II scores.

Main Methods:

  • Administered the BSID-II to 376 preterm infants at corrected ages of 6, 12, 24, and 36 months.
  • Calculated raw scores using both US and Dutch test procedures.
  • Compared raw scores, Mental Developmental Index (MDI), and Psychomotor Developmental Index (PDI) using Dutch versus US normative data.

Main Results:

  • Small but statistically significant differences were found between Dutch and US raw scores.
  • Large, clinically relevant differences were observed in MDI and PDI scores, especially at 6 and 12 months.
  • Differences suggest potential bias in Dutch normative data or a slower developmental pace in Dutch children.

Conclusions:

  • Applying international developmental tests with local standardization may yield clinically significant discrepancies.
  • The study highlights challenges in using tests developed in one country for another, even with local norms.
  • Potential bias in normative data necessitates careful interpretation of developmental assessments across different populations.